Correlation Between Novo Nordisk and Roblon AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Roblon AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Roblon AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Roblon AS, you can compare the effects of market volatilities on Novo Nordisk and Roblon AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Roblon AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Roblon AS.

Diversification Opportunities for Novo Nordisk and Roblon AS

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Novo and Roblon is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Roblon AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roblon AS and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Roblon AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roblon AS has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Roblon AS go up and down completely randomly.

Pair Corralation between Novo Nordisk and Roblon AS

Assuming the 90 days trading horizon Novo Nordisk AS is expected to under-perform the Roblon AS. In addition to that, Novo Nordisk is 2.29 times more volatile than Roblon AS. It trades about -0.14 of its total potential returns per unit of risk. Roblon AS is currently generating about -0.05 per unit of volatility. If you would invest  10,200  in Roblon AS on September 25, 2024 and sell it today you would lose (300.00) from holding Roblon AS or give up 2.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Novo Nordisk AS  vs.  Roblon AS

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Roblon AS 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Roblon AS are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating essential indicators, Roblon AS may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Novo Nordisk and Roblon AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and Roblon AS

The main advantage of trading using opposite Novo Nordisk and Roblon AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Roblon AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roblon AS will offset losses from the drop in Roblon AS's long position.
The idea behind Novo Nordisk AS and Roblon AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets